Saturday, August 6, 2016

Bristol-Myers Squibb's lucrative Opdivo fails lung cancer trail

… cancers - had failed in a lung cancer trial.
Its stock fell 16 … slowing the progression of advanced lung cancer.
Cancer is second only to … Centers for Disease Control. And lung cancer ranks as the leading cause …

No comments:

Post a Comment